{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T18:39:40Z","timestamp":1791916780146,"version":"4.3.4"},"reference-count":153,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T00:00:00Z","timestamp":1785196800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>TREM2 is a cell surface receptor that plays a crucial role in regulating immune responses, particularly in myeloid cells such as macrophages, dendritic cells, and microglia. Initially studied for its involvement in neuroinflammation and neurodegenerative diseases, while recent evidence has highlighted its broader implications in cancer and various other diseases. Recent studies show that TREM2 plays an immunoprotective role prompted by central nervous system-enriched sphingolipids during GBM progression. TREM2 overexpression represses GBM and synergizes with anti-PD-1 therapy, suggesting a potential therapeutic avenue in cancer immunotherapy. This review provides a comprehensive overview of TREM2 biology, focusing on its molecular structure, signaling pathways, and functional roles in different disease contexts. In Alzheimer\u2019s disease, TREM2 mutations are associated with altered immune responses and impaired amyloid-beta clearance, suggesting a potential therapeutic target. In cancer, TREM2 contributes to immune evasion, tumor progression, and metastasis, with emerging strategies aiming to target TREM2 to enhance anti-tumor immunity. Additionally, TREM2 is implicated in a range of other conditions, including autoimmune diseases, multiple sclerosis, and Parkinson\u2019s disease, where it may regulate inflammatory responses and tissue damage. Despite promising findings, several challenges remain in understanding TREM2\u2019s complex role across diverse diseases. Future research directions include unraveling its precise mechanisms, validating its therapeutic potential, and exploring clinical interventions targeting TREM2. This review provides a comprehensive overview of TREM2 biology, synthesizing insights from recent single-cell transcriptomics and metabolic profiling. We focus on its molecular structure, complex signaling networks, and context-dependent functional roles across diverse disease landscapes.<\/jats:p>","DOI":"10.3389\/fimmu.2026.1782384","type":"journal-article","created":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T04:26:18Z","timestamp":1785212778000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Revisiting TREM2: from multi-omics signaling networks to clinical translation"],"prefix":"10.3389","volume":"17","author":[{"given":"Jing","family":"Yang","sequence":"first","affiliation":[{"name":"Department of Emergency Surgery, The Affiliated Hospital of Qingdao University","place":["Qingdao, Shandong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dehong","family":"Wan","sequence":"additional","affiliation":[{"name":"Department of Operating Room, The Affiliated Hospital of Qingdao University","place":["Qingdao, Shandong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lina","family":"Ren","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, The Affiliated Hospital of Qingdao University","place":["Qingdao, Shandong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaqing","family":"Lv","sequence":"additional","affiliation":[{"name":"Department of Operating Room, The Affiliated Hospital of Qingdao University","place":["Qingdao, Shandong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, The Affiliated Hospital of Qingdao University","place":["Qingdao, Shandong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,28]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2020.05.003","article-title":"The physiology, pathology, and potential therapeutic applications of the TREM2 signaling pathway","volume":"181","author":"Deczkowska","year":"2020","journal-title":"Cell"},{"key":"B2","doi-asserted-by":"publisher","first-page":"110020","DOI":"10.1016\/j.neuropharm.2024.110020","article-title":"Microglia and TREM2","volume":"257","author":"Pocock","year":"2024","journal-title":"Neuropharmacology"},{"key":"B3","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1016\/j.ccell.2024.05.001","article-title":"Distinct roles of TREM2 in central nervous system cancers and peripheral cancers","volume":"42","author":"Zhong","year":"2024","journal-title":"Cancer Cell"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1093\/jleuko\/qiae134","article-title":"Brain-immune interactions: Implication for cognitive impairments in Alzheimer\u2019s disease and autoimmune disorders","volume":"116","author":"Kadam","year":"2024","journal-title":"J Leukoc Biol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"103917","DOI":"10.1016\/j.mcn.2024.103917","article-title":"TREM2 in Alzheimer\u2019s disease: Structure, function, therapeutic prospects, and activation challenges","volume":"128","author":"Zgorzynska","year":"2024","journal-title":"Mol Cell Neurosci"},{"key":"B6","doi-asserted-by":"publisher","first-page":"102596","DOI":"10.1016\/j.arr.2024.102596","article-title":"TREM2 bridges microglia and extracellular microenvironment: Mechanistic landscape and therapeutical prospects on Alzheimer\u2019s disease","volume":"103","author":"Zhao","year":"2024","journal-title":"Ageing Res Rev"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.14283\/jpad.2024.164","article-title":"Roles of TREM2 in the pathological mechanism and the therapeutic strategies of Alzheimer\u2019s disease","volume":"11","author":"Lin","year":"2024","journal-title":"J Prev Alzheimer\u2019s Dis"},{"key":"B8","doi-asserted-by":"publisher","first-page":"10738584241254118","DOI":"10.1177\/10738584241254118","article-title":"Microglia, trem2, and neurodegeneration","volume":"31","author":"Shi","year":"2024","journal-title":"Neurosci"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1097\/cm9.0000000000003000","article-title":"A systematic review of the role of TREM2 in Alzheimer\u2019s disease","volume":"137","author":"Yin","year":"2024","journal-title":"Chin Med J (Engl)"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.112042","article-title":"Current understanding on TREM-2 molecular biology and physiopathological functions","volume":"134","author":"Bharadwaj","year":"2024","journal-title":"Int Immunopharmacol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.984193","article-title":"The therapeutic potential of TREM2 in cancer","volume":"12","author":"Wolf","year":"2022","journal-title":"Front Oncol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1016\/j.cell.2020.07.013","article-title":"TREM2 modulation remodels the tumor myeloid landscape enhancing anti-PD-1 immunotherapy","volume":"182","author":"Molgora","year":"2020","journal-title":"Cell"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2019-319227","article-title":"TREM-2 defends the liver against hepatocellular carcinoma through multifactorial protective mechanisms","volume":"70","author":"Esparza-Baquer","year":"2021","journal-title":"Gut"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2023.02.032","article-title":"TREM2+ macrophages suppress CD8+ T-cell infiltration after transarterial chemoembolisation in hepatocellular carcinoma","volume":"79","author":"Tan","year":"2023","journal-title":"J Hepatol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1158\/1538-7445.am2024-6535","article-title":"Targeting estrogen receptor signaling in tumor associated myeloid cells to enhance anti-tumor immunity","volume":"84","author":"Chakraborty","year":"2024","journal-title":"Cancer Res"},{"key":"B16","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s00281-025-01038-9","article-title":"Arginine metabolism in myeloid cells in health and disease","volume":"47","author":"Karadima","year":"2025","journal-title":"Seminars in Immunopathology"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-02-336115","article-title":"Self-antigen presentation by mouse B cells results in regulatory T-cell induction rather than anergy or clonal deletion","volume":"118","author":"Morlacchi","year":"2011","journal-title":"Blood"},{"key":"B18","doi-asserted-by":"publisher","first-page":"149245","DOI":"10.1016\/j.brainres.2024.149245","article-title":"Novel insights into the role of TREM2 in cerebrovascular diseases","volume":"1846","author":"Awuah","year":"2024","journal-title":"Brain Res"},{"key":"B19","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/s40364-024-00675-w","article-title":"The double-edged role and therapeutic potential of TREM2 in atherosclerosis","volume":"12","author":"Zhu","year":"2024","journal-title":"biomark Res"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1038\/s41584-022-00790-8","article-title":"Synovial tissue macrophages in joint homeostasis, rheumatoid arthritis and disease remission","volume":"18","author":"Kurowska-Stolarska","year":"2022","journal-title":"Nat Rev Rheumatol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-020-02193-z","article-title":"TREM2 activation on microglia promotes myelin debris clearance and remyelination in a model of multiple sclerosis","volume":"140","author":"Cignarella","year":"2020","journal-title":"Acta Neuropathol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"115071","DOI":"10.1016\/j.expneurol.2024.115071","article-title":"The emerging role of the microglia triggering receptor expressed on myeloid cells (TREM) 2 in multiple sclerosis","volume":"384","author":"Farzan","year":"2024","journal-title":"Exp Neurol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1172\/jci159400","article-title":"TREM2 aggravates sepsis by inhibiting fatty acid oxidation via the SHP1\/BTK axis","volume":"135","author":"Ming","year":"2025","journal-title":"J Clin Invest"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.164.10.4991","article-title":"Cutting edge: Inflammatory responses can be triggered by TREM-1, a novel receptor expressed on neutrophils and monocytes","volume":"164","author":"Bouchon","year":"2000","journal-title":"J Immunol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1084\/jem.194.8.1111","article-title":"A DAP12-mediated pathway regulates expression of CC chemokine receptor 7 and maturation of human dendritic cells","volume":"194","author":"Bouchon","year":"2001","journal-title":"J Exp Med"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1002\/1521-4141(200103)31:3<783::aid-immu783>3.0.co;2-u","article-title":"Cloning and characterization of a novel mouse myeloid DAP12-associated receptor family","volume":"31","author":"Daws","year":"2001","journal-title":"Eur J Immunol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-023-00837-1","article-title":"The biology of TREM receptors","volume":"23","author":"Colonna","year":"2023","journal-title":"Nat Rev Immunol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1038\/s41582-018-0072-1","article-title":"TREM2 \u2014 a key player in microglial biology and Alzheimer disease","volume":"14","author":"Ulland","year":"2018","journal-title":"Nat Rev Neurol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13024-015-0040-9","article-title":"TREM2 in CNS homeostasis and neurodegenerative disease","volume":"10","author":"Painter","year":"2015","journal-title":"Mol Neurodegener"},{"key":"B30","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s13024-022-00542-y","article-title":"TREM2 in the pathogenesis of AD: a lipid metabolism regulator and potential metabolic therapeutic target","volume":"17","author":"Li","year":"2022","journal-title":"Mol Neurodegener"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1111\/jnc.15981","article-title":"Emerging roles for ITAM and ITIM receptor signaling in microglial biology and Alzheimer\u2019s disease-related amyloidosis","volume":"168","author":"Samuels","year":"2024","journal-title":"J Neurochem"},{"key":"B32","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1007\/s00018-024-05298-w","article-title":"DAP12 interacts with RER1 and is retained in the secretory pathway before assembly with TREM2","volume":"81","author":"Liu","year":"2024","journal-title":"Cell Mol Life Sci"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.201911227","article-title":"Enhancing protective microglial activities with a dual function TREM 2 antibody to the stalk region","volume":"12","author":"Schlepckow","year":"2020","journal-title":"EMBO Mol Med"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1177\/13872877251320418","article-title":"IL-34\/TREM2 modulates microglia-mediated inflammation and provides neuroprotection in a mouse model of sporadic Alzheimer\u2019s disease","volume":"104","author":"Wang","year":"2025","journal-title":"J Alzheimers Dis"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1550893","article-title":"TREM2+ macrophages: a key role in disease development","volume":"16","author":"Wang","year":"2025","journal-title":"Front Immunol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(22)00027-8","article-title":"Soluble TREM2 in CSF and its association with other biomarkers and cognition in autosomal-dominant Alzheimer\u2019s disease: a longitudinal observational study","volume":"21","author":"Morenas-Rodr\u00edguez","year":"2022","journal-title":"Lancet Neurol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.201707673","article-title":"TREM2 shedding by cleavage at the H157\u2010S158 bond is accelerated for the Alzheimer\u2019s disease\u2010associated H157Y variant","volume":"9","author":"Thornton","year":"2017","journal-title":"EMBO Mol Med"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.R115.704981","article-title":"The triggering receptor expressed on myeloid cells 2: A molecular link of neuroinflammation and neurodegenerative diseases*","volume":"291","author":"Walter","year":"2016","journal-title":"J Biol Chem"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2114486119","article-title":"Soluble TREM2 inhibits secondary nucleation of A\u03b2 fibrillization and enhances cellular uptake of fibrillar A\u03b2","volume":"119","author":"Belsare","year":"2022","journal-title":"Proc Natl Acad Sci"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2024.1515252","article-title":"sTREM2 cerebrospinal fluid levels are a potential biomarker in amyotrophic lateral sclerosis and associate with UMN burden","author":"Jiao","year":"2024","journal-title":"Front Neurol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-220102","article-title":"Cerebrospinal fluid sTREM2 has paradoxical association with brain structural damage rate in early- and late-stage Alzheimer\u2019s disease","volume":"88","author":"Leng","year":"2022","journal-title":"J Alzheimers Dis"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.adx0027","article-title":"Systematic analysis of cellular cross-talk reveals a role for SEMA6D-TREM2 regulating microglial function in Alzheimer\u2019s disease","volume":"17","author":"D\u2019Oliveira Albanus","year":"2026","journal-title":"Sci Transl Med"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1093\/gigascience\/giaf137","article-title":"Multi-omics and high-spatial-resolution omics: deciphering complexity in neurological disorders","volume":"14","author":"Liu","year":"2025","journal-title":"GigaScience"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1016\/j.apsb.2025.07.030","article-title":"Artificial intelligence-driven multi-omics approaches in Alzheimer\u2019s disease: Progress, challenges, and future directions","volume":"15","author":"Ren","year":"2025","journal-title":"Acta Pharm Sin B"},{"key":"B45","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1016\/j.cell.2020.06.032","article-title":"Coupled scRNA-Seq and intracellular protein activity reveal an immunosuppressive role of TREM2 in cancer","volume":"182","author":"Katzenelenbogen","year":"2020","journal-title":"Cell"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202412227","article-title":"CRISPR-MI and scRNA-Seq reveal TREM2\u2019s function in monocyte infiltration and macrophage apoptosis during abdominal aortic aneurysm development","volume":"12","author":"Lu","year":"2025","journal-title":"Adv Sci"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-221070","article-title":"Untangling the role of TREM2 in conjugation with microglia in neuronal dysfunction: A hypothesis on a novel pathway in the pathophysiology of Alzheimer\u2019s disease","volume":"94","author":"Basha","year":"2023","journal-title":"J Alzheimers Dis"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-025-03337-2","article-title":"TREM2 affects DAM-like cell transformation in the acute phase of TBI in mice by regulating microglial glycolysis","volume":"22","author":"Wang","year":"2025","journal-title":"J Neuroinflamm"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.3390\/diseases13020060","article-title":"TREM2 alleviates neuroinflammation by maintaining cellular metabolic homeostasis and mitophagy activity during early inflammation","volume":"13","author":"Hu","year":"2025","journal-title":"Diseases"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000200527","article-title":"Decoding TREM2 signaling pathways","volume":"13","author":"Che","year":"2026","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2025.03.016","article-title":"Niche-specific therapeutic targeting of myeloid cells in the central nervous system","volume":"58","author":"Frosch","year":"2025","journal-title":"Immunity"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellimm.2024.104882","article-title":"Unveiling the impact of TREM-2+ macrophages in metabolic disorders","author":"Telemaco Contreras Colmenares","year":"2024","journal-title":"Cell Immunol"},{"key":"B53","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1038\/s41698-025-01152-9","article-title":"TREM2-mediated regulation of myeloid cells in the tumor microenvironment: new insights and therapeutic prospects","volume":"9","author":"Huang","year":"2025","journal-title":"NPJ Precis Oncol"},{"key":"B54","doi-asserted-by":"publisher","first-page":"6770","DOI":"10.1038\/s41467-025-62132-y","article-title":"Metabolism archetype cancer cells induce protumor TREM2+ macrophages via oxLDL-mediated metabolic interplay in hepatocellular carcinoma","volume":"16","author":"Chu","year":"2025","journal-title":"Nat Commun"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1007\/s12013-024-01520-5","article-title":"TREM2 impairs glycolysis to interrupt microglial M1 polarization and inflammation via JAK2\/STAT3 axis","volume":"83","author":"Liu","year":"2025","journal-title":"Cell Biochem Biophys"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1346585","article-title":"Deciphering the link: ferroptosis and its role in glioma","volume":"15","author":"Wang","year":"2024","journal-title":"Front Immunol"},{"key":"B57","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.cell.2017.07.023","article-title":"TREM2 maintains microglial metabolic fitness in Alzheimer\u2019s disease","volume":"170","author":"Ulland","year":"2017","journal-title":"Cell"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1093\/braincomms\/fcad286","article-title":"sTREM2 is associated with attenuated tau aggregate accumulation in the presence of amyloid-\u03b2 pathology","volume":"5","author":"Nabizadeh","year":"2023","journal-title":"Brain Commun"},{"key":"B59","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s13024-025-00834-z","article-title":"TREM2 and sTREM2 in Alzheimer\u2019s disease: from mechanisms to therapies","volume":"20","author":"Zhang","year":"2025","journal-title":"Mol Neurodegener"},{"key":"B60","doi-asserted-by":"publisher","first-page":"15886","DOI":"10.1038\/s41598-020-72878-8","article-title":"Cerebrospinal fluid sTREM2 in Alzheimer\u2019s disease: comparisons between clinical presentation and AT classification","volume":"10","author":"Knapskog","year":"2020","journal-title":"Sci Rep"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.115218","article-title":"TREM2: potential therapeutic targeting of microglia for Alzheimer\u2019s disease","volume":"165","author":"Li","year":"2023","journal-title":"BioMed Pharmacother"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines10060943","article-title":"Exploring the impact of TREM2 in tumor-associated macrophages","volume":"10","author":"Khantakova","year":"2022","journal-title":"Vaccines"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20041611","article-title":"Clearance of apoptotic neurons without inflammation by microglial triggering receptor expressed on myeloid cells-2","volume":"201","author":"Takahashi","year":"2005","journal-title":"J Exp Med"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.2009.06042.x","article-title":"A role for TREM2 ligands in the phagocytosis of apoptotic neuronal cells by microglia","volume":"109","author":"Hsieh","year":"2009","journal-title":"J Neurochem"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2100356118","article-title":"Acute Trem2 reduction triggers increased microglial phagocytosis, slowing amyloid deposition in mice","volume":"118","author":"Schoch","year":"2021","journal-title":"Proc Natl Acad Sci"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24108626","article-title":"TREM2 expression and amyloid-beta phagocytosis in Alzheimer\u2019s disease","volume":"24","author":"La Rosa","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2023.110070","article-title":"TREM2 insufficiency protects against pulmonary fibrosis by inhibiting M2 macrophage polarization","volume":"118","author":"Luo","year":"2023","journal-title":"Int Immunopharmacol"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abi6802","article-title":"TREM-2 is a sensor and activator of T cell response in SARS-CoV-2 infection","volume":"7","author":"Wu","year":"2021","journal-title":"Sci Adv"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2019.05.054","article-title":"Lipid-associated macrophages control metabolic homeostasis in a Trem2-dependent manner","volume":"178","author":"Jaitin","year":"2019","journal-title":"Cell"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiaf112","article-title":"Inflammatory CD11c+ B cells induced by the TREM2 signal accelerate sepsis development","volume":"232","author":"Ming","year":"2025","journal-title":"J Infect Dis"},{"key":"B71","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00335-025-10144-w","article-title":"Single-cell and bulk RNA sequencing reveals specific Trem2 positive B cell subtype niche after myocardial infarction in mice","volume":"36","author":"Qiu","year":"2025","journal-title":"Mamm Genome"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.646523","article-title":"Systematic pan-cancer analysis identifies TREM2 as an immunological and prognostic biomarker","volume":"12","author":"Cheng","year":"2021","journal-title":"Front Immunol"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2022.109231","article-title":"Activation of TREM2 attenuates neuroinflammation via PI3K\/Akt signaling pathway to improve postoperative cognitive dysfunction in mice","volume":"219","author":"Han","year":"2022","journal-title":"Neuropharmacology"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1016\/s1474-4422(22)00087-4","article-title":"Dynamics of neuroinflammation in Alzheimer\u2019s disease","volume":"21","author":"Smirnov","year":"2022","journal-title":"Lancet Neurol"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1080\/00207454.2022.2150844","article-title":"TREM2 R47H variant and risk for Alzheimer\u2019s disease: assessment in a Greek population and updated meta-analysis","volume":"134","author":"Rikos","year":"2024","journal-title":"Int J Neurosci"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmb.2022.167470","article-title":"Variant TREM2 signaling in Alzheimer\u2019s disease","volume":"434","author":"Olufunmilayo","year":"2022","journal-title":"J Mol Biol"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1401528","article-title":"From mechanism to therapy: the journey of CD24 in cancer","volume":"15","author":"Zhao","year":"2024","journal-title":"Front Immunol"},{"key":"B78","doi-asserted-by":"publisher","first-page":"101739","DOI":"10.1016\/j.smim.2023.101739","article-title":"TREM2: a new player in the tumor microenvironment","volume":"67","author":"Molgora","year":"2023","journal-title":"Semin Immunol"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.109844","article-title":"Targeting TREM2 on tumor-associated macrophages enhances immunotherapy","volume":"37","author":"Binnewies","year":"2021","journal-title":"Cell Rep"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1002\/JLB.6RU0918-353RRRR","article-title":"The expanding family of noncanonical regulatory cell subsets","volume":"106","author":"Zhao","year":"2019","journal-title":"J Leukoc Biol"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.ade3559","article-title":"TREM2 inhibition triggers antitumor cell activity of myeloid cells in glioblastoma","volume":"9","author":"Sun","year":"2023","journal-title":"Sci Adv"},{"key":"B82","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00109-024-02504-x","article-title":"The role of inhibitory immune checkpoint receptors in the pathogenesis of Alzheimer\u2019s disease","volume":"103","author":"Salminen","year":"2024","journal-title":"J Mol Med"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2021.09.014","article-title":"Microglia: immune and non-immune functions","volume":"54","author":"Borst","year":"2021","journal-title":"Immunity"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1016\/j.conb.2021.09.003","article-title":"Secretases in Alzheimer\u2019s disease: novel insights into proteolysis of APP and TREM2","volume":"72","author":"Lichtenthaler","year":"2022","journal-title":"Curr Opin Neurobiol"},{"key":"B85","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12974-021-02309-6","article-title":"The semantics of microglia activation: neuroinflammation, homeostasis, and stress","volume":"18","author":"Woodburn","year":"2021","journal-title":"J Neuroinflamm"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2024.122556","article-title":"CAR T treatment beyond cancer: hope for immunomodulatory therapy of non-cancerous diseases","volume":"344","author":"Yang","year":"2024","journal-title":"Life Sci"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1211851","article-title":"TREM2 variants in Alzheimer\u2019s disease","volume":"368","author":"Guerreiro","year":"2013","journal-title":"N Engl J Med"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurobiolaging.2013.08.011","article-title":"Assessing the role of the TREM2 p.R47H variant as a risk factor for Alzheimer\u2019s disease and frontotemporal dementia","volume":"35","author":"Ruiz","year":"2014","journal-title":"Neurobiol Aging"},{"key":"B89","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s13024-018-0298-9","article-title":"New insights into the role of TREM2 in Alzheimer\u2019s disease","volume":"13","author":"Gratuze","year":"2018","journal-title":"Mol Neurodegener"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1038\/nrn.2016.7","article-title":"TREM2 variants: new keys to decipher Alzheimer disease pathogenesis","volume":"17","author":"Colonna","year":"2016","journal-title":"Nat Rev Neurosci"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.3390\/molecules29071478","article-title":"Neuroinflammation of microglial regulation in Alzheimer\u2019s disease: therapeutic approaches","volume":"29","author":"Chen","year":"2024","journal-title":"Molecules"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1334922","article-title":"Surprising magic of CD24 beyond cancer","volume":"14","author":"Wang","year":"2024","journal-title":"Front Immunol"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M115.645986","article-title":"DAP12 stabilizes the C-terminal fragment of the triggering receptor expressed on myeloid cells-2 (TREM2) and protects against LPS-induced pro-inflammatory response","volume":"290","author":"Zhong","year":"2015","journal-title":"J Biol Chem"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2017.08.001","article-title":"Modulation of \u03b3- and \u03b2-secretases as early prevention against Alzheimer\u2019s disease","volume":"83","author":"Voytyuk","year":"2018","journal-title":"Biol Psychiatry"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2017.08.010","article-title":"Anti-amyloid-\u03b2 monoclonal antibodies for Alzheimer\u2019s disease: pitfalls and promise","volume":"83","author":"van Dyck","year":"2018","journal-title":"Biol Psychiatry"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2017.12.002","article-title":"Emerging mechanisms in Alzheimer\u2019s disease and their therapeutic implications","volume":"83","author":"Strittmatter","year":"2018","journal-title":"Biol Psychiatry"},{"key":"B97","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1016\/j.neuron.2018.02.002","article-title":"Elevated TREM2 gene dosage reprograms microglia responsivity and ameliorates pathological phenotypes in Alzheimer\u2019s disease models","volume":"97","author":"Lee","year":"2018","journal-title":"Neuron"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1016\/j.jalz.2016.10.005","article-title":"A candidate regulatory variant at the TREM gene cluster associates with decreased Alzheimer\u2019s disease risk and increased TREML1 and TREM2 brain gene expression","volume":"13","author":"Carrasquillo","year":"2017","journal-title":"Alzheimers Dement"},{"key":"B99","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s13024-017-0216-6","article-title":"TREM2 deficiency exacerbates tau pathology through dysregulated kinase signaling in a mouse model of tauopathy","volume":"12","author":"Bemiller","year":"2017","journal-title":"Mol Neurodegener"},{"key":"B100","doi-asserted-by":"publisher","first-page":"15318","DOI":"10.1038\/s41598-024-66211-w","article-title":"Neuroimaging biomarkers and CSF sTREM2 levels in Alzheimer\u2019s disease: a longitudinal study","volume":"14","author":"Nabizadeh","year":"2024","journal-title":"Sci Rep"},{"key":"B101","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1186\/s12974-024-03163-y","article-title":"Tracking neuroinflammatory biomarkers in Alzheimer\u2019s disease: a strategy for individualized therapeutic approaches","volume":"21","author":"Lista","year":"2024","journal-title":"J Neuroinflamm"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-023-00687-4","article-title":"Proteo-genomics of soluble TREM2 in cerebrospinal fluid provides novel insights and identifies novel modulators for Alzheimer\u2019s disease","volume":"19","author":"Wang","year":"2024","journal-title":"Mol Neurodegener"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1038\/nrclinonc.2016.217","article-title":"Tumour-associated macrophages as treatment targets in oncology","volume":"14","author":"Mantovani","year":"2017","journal-title":"Nat Rev Clin Oncol"},{"key":"B104","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.immuni.2014.06.010","article-title":"Tumor-associated macrophages: from mechanisms to therapy","volume":"41","author":"Noy","year":"2014","journal-title":"Immunity"},{"key":"B105","doi-asserted-by":"publisher","first-page":"3200","DOI":"10.21037\/tcr-24-201","article-title":"Systematic analysis of TREM2 and its carcinogenesis in pancreatic cancer","volume":"13","author":"Zheng","year":"2024","journal-title":"Transl Cancer Res"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/noad257","article-title":"Triggering receptor expressed on myeloid cells 2 (TREM2) regulates phagocytosis in glioblastoma","volume":"26","author":"Peshoff","year":"2024","journal-title":"Neuro Oncol"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.cir-24-1088","article-title":"Targeting myeloid Trem2 reprograms the immunosuppressive niche and potentiates checkpoint immunotherapy in NASH-driven hepatocarcinogenesis","volume":"13","author":"Wang","year":"2025","journal-title":"Cancer Immunol Res"},{"key":"B108","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1097\/hep.0000000000001098","article-title":"TREM2 macrophages mediate the beneficial effects of bariatric surgery against MASH","volume":"81","author":"Fredrickson","year":"2024","journal-title":"Hepatology"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1161\/atvbaha.124.320797","article-title":"Trem2 agonist reprograms foamy macrophages to promote atherosclerotic plaque stability\u2014brief report","volume":"44","author":"Patterson","year":"2024","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1523\/jneurosci.2347-23.2024","article-title":"Neutral or detrimental effects of TREM2 agonist antibodies in preclinical models of Alzheimer\u2019s disease and multiple sclerosis","volume":"44","author":"Etxeberria","year":"2024","journal-title":"J Neurosci"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.adi5374","article-title":"TREM2 deficiency reprograms intestinal macrophages and microbiota to enhance anti\u2013PD-1 tumor immunotherapy","volume":"9","author":"Di Luccia","year":"2024","journal-title":"Sci Immunol"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2024.42.16_suppl.e14649","article-title":"The rationale of reprogramming TREM2+ macrophages for overcoming the resistance to immune checkpoint inhibitors in pancreatic adenocarcinoma","author":"Ravichandran","year":"2024"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-024-03232-2","article-title":"A comprehensive review of AAV-mediated strategies targeting microglia for therapeutic intervention of neurodegenerative diseases","volume":"21","author":"Zhou","year":"2024","journal-title":"J Neuroinflamm"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.113446","article-title":"TREM2 signaling in Parkinson\u2019s disease: regulation of microglial function and \u03b1-synuclein pathology","volume":"143","author":"Yin","year":"2024","journal-title":"Int Immunopharmacol"},{"key":"B115","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1001\/jamaneurol.2013.579","article-title":"Using exome sequencing to reveal mutations in TREM2 presenting as a frontotemporal dementia\u2013like syndrome without bone involvement","volume":"70","author":"Guerreiro","year":"2013","journal-title":"JAMA Neurol"},{"key":"B116","doi-asserted-by":"publisher","first-page":"2419.e23","DOI":"10.1016\/j.neurobiolaging.2014.04.010","article-title":"Homozygous TREM2 mutation in a family with atypical frontotemporal dementia","volume":"35","author":"Le Ber","year":"2014","journal-title":"Neurobiol Aging"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1096\/fj.201900992R","article-title":"TREM2 deficiency aggravates \u03b1-synuclein\u2013induced neurodegeneration and neuroinflammation in Parkinson\u2019s disease models","volume":"33","author":"Guo","year":"2019","journal-title":"FASEB J"},{"key":"B118","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1038\/s41420-025-02538-1","article-title":"TREM2 deficiency exacerbates cognitive impairment by aggravating \u03b1-synuclein-induced lysosomal dysfunction in Parkinson\u2019s disease","volume":"11","author":"Zhu","year":"2025","journal-title":"Cell Death Discov"},{"key":"B119","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1007\/s12031-019-01424-7","article-title":"Analysis of cerebrospinal fluid soluble TREM2 and polymorphisms in sporadic Parkinson\u2019s disease in a Chinese population","volume":"70","author":"Peng","year":"2020","journal-title":"J Mol Neurosci"},{"key":"B120","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1750-1326-8-19","article-title":"TREM2 in neurodegeneration: evidence for association of the p. R47H variant with frontotemporal dementia and Parkinson\u2019s disease","volume":"8","author":"Rayaprolu","year":"2013","journal-title":"Mol Neurodegener"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2015.11.026","article-title":"TREM2 rare variant p. R47H is not associated with Parkinson\u2019s disease","volume":"23","author":"Mengel","year":"2016","journal-title":"Parkinsonism Relat Disord"},{"key":"B122","doi-asserted-by":"publisher","first-page":"934.e7","DOI":"10.1016\/j.neurobiolaging.2013.09.017","article-title":"Heterozygous TREM2 mutations in frontotemporal dementia","volume":"35","author":"Borroni","year":"2014","journal-title":"Neurobiol Aging"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awae014","article-title":"TREM2 variants that cause early dementia and increase Alzheimer\u2019s disease risk affect gene splicing","volume":"147","author":"Kiianitsa","year":"2024","journal-title":"Brain"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1038\/s41421-024-00666-z","article-title":"Immunological aspects of central neurodegeneration","volume":"10","author":"Niso-Santano","year":"2024","journal-title":"Cell Discov"},{"key":"B125","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1084\/jem.20160844","article-title":"Soluble TREM2 induces inflammatory responses and enhances microglial survival","volume":"214","author":"Zhong","year":"2017","journal-title":"J Exp Med"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbi.2023.01.013","article-title":"Profiling TREM2 expression in amyotrophic lateral sclerosis","volume":"109","author":"Jeric\u00f3","year":"2023","journal-title":"Brain Behav Immun"},{"key":"B127","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1038\/s41593-021-00975-6","article-title":"TREM2 interacts with TDP-43 and mediates microglial neuroprotection against TDP-43-related neurodegeneration","volume":"25","author":"Xie","year":"2022","journal-title":"Nat Neurosci"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2022.105630","article-title":"Soluble TREM2: innocent bystander or active player in neurological diseases","volume":"165","author":"Filipello","year":"2022","journal-title":"Neurobiol Dis"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2018.05.003","article-title":"Disease-associated microglia: a universal immune sensor of neurodegeneration","volume":"173","author":"Deczkowska","year":"2018","journal-title":"Cell"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-022-03100-1","article-title":"TREM2 and microglia contribute to the synaptic plasticity: from physiology to pathology","volume":"60","author":"Yu","year":"2023","journal-title":"Mol Neurobiol"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.26508\/lsa.202402796","article-title":"Targeting TREM2 signaling shows limited impact on cerebrovascular calcification","volume":"8","author":"Sridhar","year":"2025","journal-title":"Life Sci Alliance"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202305614","article-title":"TREM2\u2010IGF1 mediated glucometabolic enhancement underlies microglial neuroprotective properties during ischemic stroke","volume":"11","author":"Yang","year":"2024","journal-title":"Adv Sci"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.1177\/0271678X18817282","article-title":"Triggering receptor expressed on myeloid cells-2 expression in the brain is required for maximal phagocytic activity and improved neurological outcomes following experimental stroke","volume":"39","author":"Kurisu","year":"2019","journal-title":"J Cereb Blood Flow Metab"},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2024.111301","article-title":"The positive role of transforming growth factor-\u03b21 in ischemic stroke","volume":"111301","author":"Li","year":"2024","journal-title":"Cell Signal"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2024.1375729","article-title":"Mechanisms of TREM2 mediated immunosuppression and regulation of cancer progression","volume":"14","author":"Lei","year":"2024","journal-title":"Front Oncol"},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.113750","article-title":"Soluble TREM2 drives triple-negative breast cancer progression via activation of the AKT pathway","volume":"145","author":"Yin","year":"2025","journal-title":"Int Immunopharmacol"},{"key":"B137","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.trsl.2024.10.002","article-title":"Blockade of TREM2 ameliorates pulmonary inflammation and fibrosis by modulating sphingolipid metabolism","volume":"275","author":"Gu","year":"2025","journal-title":"Transl Res"},{"key":"B138","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s13046-025-03287-w","article-title":"TREM2 promotes the formation of a tumor-supportive microenvironment in hepatocellular carcinoma","volume":"44","author":"Guo","year":"2025","journal-title":"J Exp Clin Cancer Res"},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.1002\/glia.24318","article-title":"Alzheimer\u2019s disease\u2010associated R47H TREM2 increases, but wild\u2010type TREM2 decreases, microglial phagocytosis of synaptosomes and neuronal loss","volume":"71","author":"Popescu","year":"2023","journal-title":"Glia"},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2025.1576020","article-title":"The potential and challenges of TREM2-targeted therapy in Alzheimer\u2019s disease: insights from the INVOKE-2 study","author":"Ma","year":"2025","journal-title":"Front Aging Neurosci"},{"key":"B141","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s13024-018-0262-8","article-title":"The Trem2 R47H variant confers loss-of-function-like phenotypes in Alzheimer\u2019s disease","volume":"13","author":"Cheng-Hathaway","year":"2018","journal-title":"Mol Neurodegener"},{"key":"B142","doi-asserted-by":"publisher","DOI":"10.1038\/nn.4597","article-title":"Transcriptomic analysis of purified human cortical microglia reveals age-associated changes","volume":"20","author":"Galatro","year":"2017","journal-title":"Nat Neurosci"},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.1126\/science.aal3222","article-title":"An environment-dependent transcriptional network specifies human microglia identity","volume":"356","author":"Gosselin","year":"2017","journal-title":"Science (80-)"},{"key":"B144","doi-asserted-by":"publisher","first-page":"3666","DOI":"10.1212\/WNL.0000000000205296","article-title":"Interim results on VGL101 from IGNITE: first interventional phase 2 study in patients with adultonset leukoencephalopathy with axonal spheroids and pigmented glia (ALSP) (S28.005)","volume":"102","author":"Lynch","year":"2024","journal-title":"Neurology"},{"key":"B145","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2023.1259012","article-title":"Emerging Alzheimer\u2019s disease therapeutics: promising insights from lipid metabolism and microglia-focused interventions","volume":"15","author":"Tobeh","year":"2023","journal-title":"Front Aging Neurosci"},{"key":"B146","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s13024-020-00374-8","article-title":"Dynamic changes of CSF sTREM2 in preclinical Alzheimer\u2019s disease: the CABLE study","volume":"15","author":"Ma","year":"2020","journal-title":"Mol Neurodegener"},{"key":"B147","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1016\/j.neuron.2021.02.010","article-title":"Trem2 restrains the enhancement of tau accumulation and neurodegeneration by \u03b2-amyloid pathology","volume":"109","author":"Lee","year":"2021","journal-title":"Neuron"},{"key":"B148","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1710311114","article-title":"TREM2 deficiency attenuates neuroinflammation and protects against neurodegeneration in a mouse model of tauopathy","volume":"114","author":"Leyns","year":"2017","journal-title":"Proc Natl Acad Sci"},{"key":"B149","doi-asserted-by":"publisher","DOI":"10.1155\/2023\/8101837","article-title":"TREM2 as a potential immune\u2010related biomarker of prognosis in patients with skin cutaneous melanoma microenvironment","volume":"2023","author":"Zhu","year":"2023","journal-title":"Dis Markers"},{"key":"B150","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/s12943-023-01830-x","article-title":"Target delivery of a PD-1-TREM2 scFv by CAR-T cells enhances anti-tumor efficacy in colorectal cancer","volume":"22","author":"Chen","year":"2023","journal-title":"Mol Cancer"},{"key":"B151","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2024.114875","article-title":"Comparing neoantigen cancer vaccines and immune checkpoint therapy unveils an effective vaccine and anti-TREM2 macrophage-targeting dual therapy","volume":"43","author":"Keshari","year":"2024","journal-title":"Cell Rep"},{"key":"B152","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1038\/s41467-019-09118-9","article-title":"Soluble TREM2 ameliorates pathological phenotypes by modulating microglial functions in an Alzheimer\u2019s disease model","volume":"10","author":"Zhong","year":"2019","journal-title":"Nat Commun"},{"key":"B153","doi-asserted-by":"publisher","first-page":"13050","DOI":"10.21203\/rs.3.rs-279288\/v1","article-title":"The relationship of soluble TREM2 to other biomarkers of sporadic Alzheimer\u2019s disease","volume":"11","author":"Park","year":"2021","journal-title":"Sci Rep"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1782384\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T04:26:19Z","timestamp":1785212779000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1782384\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,28]]},"references-count":153,"alternative-id":["10.3389\/fimmu.2026.1782384"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1782384","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,28]]},"article-number":"1782384"}}